{"id":254,"date":"2015-03-18T14:12:45","date_gmt":"2015-03-18T15:12:45","guid":{"rendered":"http:\/\/brtfinancial.com\/blog\/zero-down-no-down-payment-100-financing-for-medical-dental-and-healthcare-practices-more-news-astrazeneca-two-in-one-drug-succeeds-in-lung-disease-test-more-03182015\/"},"modified":"2017-03-08T21:02:25","modified_gmt":"2017-03-08T22:02:25","slug":"zero-down-no-down-payment-100-financing-for-medical-dental-and-healthcare-practices-more-news-astrazeneca-two-in-one-drug-succeeds-in-lung-disease-test-more-03182015","status":"publish","type":"post","link":"https:\/\/brtfinancial.com\/blog\/zero-down-no-down-payment-100-financing-for-medical-dental-and-healthcare-practices-more-news-astrazeneca-two-in-one-drug-succeeds-in-lung-disease-test-more-03182015\/","title":{"rendered":"100% Financing For Medical, Dental And Healthcare Practices! + More News: AstraZeneca two-in-one drug succeeds in lung disease test + MORE 03\/18\/2015"},"content":{"rendered":"<div class=\"bb_header_text\">\n<h1>Medical Professional financing for your medical practice!&nbsp; Learn how to get funding with <a href=\"http:\/\/www.doctor-financing.com\">medical practice financing<\/a>. More Info Here!<\/h1>\n<p><\/p>\n<h2>Call: 904-551-6090<\/h2>\n<p>\n<img decoding=\"async\" src=\"http:\/\/www.doctor-financing.com\/img\/brt-pic.jpg\"><\/p>\n<p>Over the years we have been able to finance a lot of start up medical practice units with excellent services. The great repayments rates that are stated by the company will give you the chance to order your finances well. All the low repayment rates are aimed at financing your financial program by virtue that it was specifically designed to help fresh medical doctors who are in need of financial assistance to start up their medical practice. With confidence, you should make our company your financial source as we are dedicated to make your dreams a reality.<\/p>\n<h3>Read The Interesting Snippets Below For Exciting Health-Care News!<\/h3>\n<\/div>\n<div class=\"bb-itemwrap\" style=\"margin-bottom:40px\">\n<div style=\"margin:5px 5px 5px 0\">\n<h2 class=\"bb_itemtitle\"><a href=\"http:\/\/feeds.reuters.com\/~r\/reuters\/healthNews\/~3\/12m4ih09Rio\/story01.htm\" title=\"U.S. reports outbreak of low-pathogenic bird flu in California: OIE\" rel=\"follow\" rev=\"http:\/\/www.reuters.com\/\" target=\"_blank\">U.S. reports outbreak of low-pathogenic bird flu in California: OIE<\/a><\/h2>\n<p><small style=\"font-size:11px;font-style:italic\"> &#8211; http:\/\/www.reuters.com\/<\/small><\/div>\n<div class=\"bb-post-content\">PARIS (Reuters) &#8211; The United States reported an outbreak of low-pathogenic H7N3 bird flu on a turkey farm in California, the World Organisation for Animal Health (OIE) said on Wednesday.<\/p>\n<\/div>\n<p><a class=\"bb_readmore\" href=\"http:\/\/feeds.reuters.com\/~r\/reuters\/healthNews\/~3\/12m4ih09Rio\/story01.htm\" target=\"_blank\" title=\"Continue reading on http:\/\/www.reuters.com\/ &#187;\" rel=\"follow\"><b>Continue Reading On http:\/\/www.reuters.com\/ \u00bb<\/b><\/a><\/div>\n<div class=\"bb-itemwrap\" style=\"margin-bottom:40px\">\n<div style=\"margin:5px 5px 5px 0\">\n<h2 class=\"bb_itemtitle\"><a href=\"http:\/\/rss.nytimes.com\/c\/34625\/f\/640346\/s\/446f55d5\/sc\/14\/l\/0Lwell0Bblogs0Bnytimes0N0C20A150C0A30C160Clooking0Efor0Eparkinsons0Esooner0C0Dpartner0Frss0Gemc0Frss\/story01.htm\" title=\"Personal Health: Looking for Parkinson\u2019s Sooner\" rel=\"follow\" rev=\"http:\/\/www.nytimes.com\/\" target=\"_blank\">Personal Health: Looking for Parkinson\u2019s Sooner<\/a><\/h2>\n<p><small style=\"font-size:11px;font-style:italic\"> &#8211; http:\/\/www.nytimes.com\/<\/small><\/div>\n<div class=\"bb-post-content\"><img loading=\"lazy\" decoding=\"async\" src=\"http:\/\/brtfinancial.com\/blog\/wp-content\/uploads\/practice-loans-1426691563-1826964117.jpg\" alt=\"Personal Health: Looking for Parkinson\u2019s Sooner\" width=\"151\" height=\"151\" class=\"alignright\" \/>REM sleep behavior disorder, characterized by a tendency to act out one\u2019s dreams while asleep, is one of the strongest prediagnostic symptoms.<\/div>\n<p><a class=\"bb_readmore\" href=\"http:\/\/rss.nytimes.com\/c\/34625\/f\/640346\/s\/446f55d5\/sc\/14\/l\/0Lwell0Bblogs0Bnytimes0N0C20A150C0A30C160Clooking0Efor0Eparkinsons0Esooner0C0Dpartner0Frss0Gemc0Frss\/story01.htm\" target=\"_blank\" title=\"Continue reading on http:\/\/www.nytimes.com\/ &#187;\" rel=\"follow\"><b>Continue Reading On http:\/\/www.nytimes.com\/ \u00bb<\/b><\/a><\/div>\n<div class=\"bb-itemwrap\" style=\"margin-bottom:40px\">\n<div style=\"margin:5px 5px 5px 0\">\n<h2 class=\"bb_itemtitle\"><a href=\"http:\/\/feeds.reuters.com\/~r\/reuters\/healthNews\/~3\/IRBcZ2zLC6Y\/story01.htm\" title=\"FDA panel to discuss Ebola vaccine development in May\" rel=\"follow\" rev=\"http:\/\/www.reuters.com\/\" target=\"_blank\">FDA panel to discuss Ebola vaccine development in May<\/a><\/h2>\n<p><small style=\"font-size:11px;font-style:italic\"> &#8211; http:\/\/www.reuters.com\/<\/small><\/div>\n<div class=\"bb-post-content\">(Reuters) &#8211; The U.S. Food and Drug Administration said an advisory panel will discuss the development of Ebola vaccines, days after an American health worker was flown back after being tested positive for Ebola in Sierra Leone.<\/p>\n<\/div>\n<p><a class=\"bb_readmore\" href=\"http:\/\/feeds.reuters.com\/~r\/reuters\/healthNews\/~3\/IRBcZ2zLC6Y\/story01.htm\" target=\"_blank\" title=\"Continue reading on http:\/\/www.reuters.com\/ &#187;\" rel=\"follow\"><b>Continue Reading On http:\/\/www.reuters.com\/ \u00bb<\/b><\/a><\/div>\n<div class=\"bb-itemwrap\" style=\"margin-bottom:40px\">\n<div style=\"margin:5px 5px 5px 0\">\n<h2 class=\"bb_itemtitle\"><a href=\"http:\/\/feeds.reuters.com\/~r\/reuters\/USVideoBusiness\/~3\/4y2jScnpgLI\/att-directv-deal-faces-less-dc-heat\" title=\"AT&amp;T-DirecTV deal faces less DC heat\" rel=\"follow\" rev=\"reuters.com\" target=\"_blank\">AT&amp;T-DirecTV deal faces less DC heat<\/a><\/h2>\n<p><small style=\"font-size:11px;font-style:italic\"> &#8211; reuters.com<\/small><\/div>\n<div class=\"bb-post-content\">AT&amp;T&#8217;s proposed acquisition of satellite television company DirecTV is getting a smooth ride from U.S. regulators in Washington compared to the deal between the nation&#8217;s two biggest cable operators.<\/p>\n<\/div>\n<p><a class=\"bb_readmore\" href=\"http:\/\/feeds.reuters.com\/~r\/reuters\/USVideoBusiness\/~3\/4y2jScnpgLI\/att-directv-deal-faces-less-dc-heat\" target=\"_blank\" title=\"Continue reading on reuters.com &#187;\" rel=\"follow\"><b>Continue Reading On reuters.com \u00bb<\/b><\/a><\/div>\n<div class=\"bb-itemwrap\" style=\"margin-bottom:40px\">\n<div style=\"margin:5px 5px 5px 0\">\n<h2 class=\"bb_itemtitle\"><a href=\"http:\/\/feeds.reuters.com\/~r\/reuters\/healthNews\/~3\/_0w7RTNn2Eo\/story01.htm\" title=\"Exclusive: U.S. to roll back &#039;lost pleasure&#039; approach on health rules\" rel=\"follow\" rev=\"http:\/\/www.reuters.com\/\" target=\"_blank\">Exclusive: U.S. to roll back &#039;lost pleasure&#039; approach on health rules<\/a><\/h2>\n<p><small style=\"font-size:11px;font-style:italic\"> &#8211; http:\/\/www.reuters.com\/<\/small><\/div>\n<div class=\"bb-post-content\">NEW YORK\/WASHINGTON (Reuters) &#8211; The U.S. government is preparing to roll back a widely criticized approach to public health, in which the &#8220;lost pleasure&#8221; people might suffer if they quit smoking or chose to eat healthier foods was used to reduce the projected benefits of new regulations, government officials told Reuters&#8230;<\/div>\n<p><a class=\"bb_readmore\" href=\"http:\/\/feeds.reuters.com\/~r\/reuters\/healthNews\/~3\/_0w7RTNn2Eo\/story01.htm\" target=\"_blank\" title=\"Continue reading on http:\/\/www.reuters.com\/ &#187;\" rel=\"follow\"><b>Continue Reading On http:\/\/www.reuters.com\/ \u00bb<\/b><\/a><\/div>\n<div class=\"bb-itemwrap\" style=\"margin-bottom:40px\">\n<div style=\"margin:5px 5px 5px 0\">\n<h2 class=\"bb_itemtitle\"><a href=\"http:\/\/feeds.reuters.com\/~r\/reuters\/healthNews\/~3\/TVNGqK4N9Ls\/story01.htm\" title=\"AstraZeneca two-in-one drug succeeds in lung disease test\" rel=\"follow\" rev=\"http:\/\/www.reuters.com\/\" target=\"_blank\">AstraZeneca two-in-one drug succeeds in lung disease test<\/a><\/h2>\n<p><small style=\"font-size:11px;font-style:italic\"> &#8211; http:\/\/www.reuters.com\/<\/small><\/div>\n<div class=\"bb-post-content\">LONDON (Reuters) &#8211; AstraZeneca said on Wednesday its experimental lung drug PT003 for chronic lung disease had proved successful in two final-stage Phase III trials, boosting hopes for the company&#8217;s respiratory pipeline.<\/p>\n<\/div>\n<p><a class=\"bb_readmore\" href=\"http:\/\/feeds.reuters.com\/~r\/reuters\/healthNews\/~3\/TVNGqK4N9Ls\/story01.htm\" target=\"_blank\" title=\"Continue reading on http:\/\/www.reuters.com\/ &#187;\" rel=\"follow\"><b>Continue Reading On http:\/\/www.reuters.com\/ \u00bb<\/b><\/a><\/div>\n<p>[Buzz_Burner_Fresh_Updates]<\/p>\n<div class=\"bb_footer_text\">\n<h1>Dental And Medical Practice Financing!<\/h1>\n<p>\n<img decoding=\"async\" src=\"http:\/\/www.doctor-financing.com\/images\/back_header_big.png\"><\/div>\n","protected":false},"excerpt":{"rendered":"<p>Medical Professional financing for your medical practice!&nbsp; Learn how to get funding with medical practice financing. More Info Here! Call: 904-551-6090 Over the years we have been able to finance a lot of start up medical practice units with excellent services. The great repayments rates that are stated by the company will give you the [&hellip;]<\/p>\n","protected":false},"author":13,"featured_media":0,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[1],"tags":[8,12,9,15,10],"class_list":["post-254","post","type-post","status-publish","format-standard","hentry","category-dental-medical-practice-financing-programs","tag-doctor-financing","tag-doctor-practice-financing","tag-medical-practice-loans","tag-practice-loans","tag-practice-working-capital"],"_links":{"self":[{"href":"https:\/\/brtfinancial.com\/blog\/wp-json\/wp\/v2\/posts\/254","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/brtfinancial.com\/blog\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/brtfinancial.com\/blog\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/brtfinancial.com\/blog\/wp-json\/wp\/v2\/users\/13"}],"replies":[{"embeddable":true,"href":"https:\/\/brtfinancial.com\/blog\/wp-json\/wp\/v2\/comments?post=254"}],"version-history":[{"count":0,"href":"https:\/\/brtfinancial.com\/blog\/wp-json\/wp\/v2\/posts\/254\/revisions"}],"wp:attachment":[{"href":"https:\/\/brtfinancial.com\/blog\/wp-json\/wp\/v2\/media?parent=254"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/brtfinancial.com\/blog\/wp-json\/wp\/v2\/categories?post=254"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/brtfinancial.com\/blog\/wp-json\/wp\/v2\/tags?post=254"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}